Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.30
-0.20 (-0.37%)
Aug 12, 2025, 12:52 PM CST
-0.37%
Market Cap4.64B
Revenue (ttm)4.44B
Net Income (ttm)-347.80M
Shares Out86.75M
EPS (ttm)-4.01
PE Ration/a
Forward PEn/a
Dividend1.00 (1.87%)
Ex-Dividend DateJul 7, 2025
Volume45,343
Average Volume86,953
Open53.60
Previous Close53.50
Day's Range53.00 - 54.10
52-Week Range40.05 - 60.70
Beta0.24
RSI52.06
Earnings DateAug 11, 2025

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.